SPACs in the Healthcare Sector: Structuring Transactions, Considerations and Challenges for Companies, Investors

Recording of a 90-minute CLE video webinar with Q&A


Conducted on Wednesday, July 21, 2021

Recorded event now available

or call 1-800-926-7926
Course Materials

This CLE course will guide healthcare counsel on special purpose acquisition companies (SPACs). The panel will examine SPAC formation and structuring. The panel will discuss the benefits and considerations for both private and public companies. The panel will also discuss challenges for the parties involved and offer best practices for structuring SPAC IPOs.

Description

Since the pandemic created uncertainty in the market, there has been an increase in special purpose acquisition companies (SPACs). These shell companies take companies public without going through the traditional, lengthy IPO process. SPACs offer a cheaper, quicker, and often less risky path.

Healthcare SPACs bring new opportunities to market, and SPACs are helping investors get access. SPAC IPOs offer more certainty with pricing as both companies discuss and agree upon a specific deal, unlike the pricing fluctuation in a traditional IPO. Also, as a SPAC, there is much less scrutiny and nothing to disclose. Already in 2021, there have been some big SPAC deals in the healthcare sector.

Listen as our authoritative panel of healthcare attorneys examines SPAC formation and structuring. The panel will discuss the benefits and considerations for both private and public companies. The panel will also discuss challenges for the parties involved and offer best practices for structuring SPAC IPOs.

READ MORE

Outline

  1. Recent developments of SPACs in healthcare
  2. Overview of SPACs and key features
  3. Structuring considerations and issues of concern
    1. Private company considerations
    2. Public company considerations
    3. Sponsor considerations
  4. Best practices for counsel, sponsors, and sellers

Benefits

The panel will review these and other key issues:

  • What factors should be considered when determining the structure of SPACs in the healthcare industry?
  • How do the incentives created under SPACs differ for the sponsor and the investors?
  • What are the potential tax consequences to investors?

Faculty

Smith, Michael
Michael A. Smith

Partner
Nixon Peabody

Mr. Smith has more than 25 years of experience advising international and domestic companies on global capital markets...  |  Read More

Washlick, John
John R. Washlick

Shareholder
Buchanan Ingersoll & Rooney

Mr. Washlick focuses his practice on healthcare transactions and corporate compliance. He is Co-Chair of the...  |  Read More

Access Anytime, Anywhere

Strafford will process CLE credit for one person on each recording. All formats include course handouts.

To find out which recorded format will provide the best CLE option, select your state:

CLE On-Demand Video

Download